Glenmark Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep' 24	Jun' 24	Mar' 24	Dec' 23	Sep' 23

Sales

506.88

588.62

536.60

572.80

595.36

Operating profit

134.36

159.49

141.45

172.56

167.08

Interest

0.34

0.35

0.36

0.39

0.40

Gross profit

142.55

164.63

144.21

173.86

172.05

EPS (Rs)

7.78

9.10

7.99

9.69

9.69

Other income

8.53

5.49

3.13

1.69

5.37

Stock adjustment

-13.88

41.43

-9.14

-0.93

3.68

Raw material

239.08

246.36

247.84

243.13

269.40

Power and fuel

-

-

-

-

-

Employee expenses

62.44

56.84

72.26

71.05

66.71

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

84.89

84.50

84.20

87.00

88.49

Provisions made

-

-

-

-

-

Depreciation

15.09

14.39

14.53

13.18

13.13

Taxation

32.14

38.76

31.74

41.92

40.19

Net profit / loss

95.32

111.48

97.94

118.77

118.74

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

24.51

24.51

24.51

24.51

24.51

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.51

27.09

26.36

30.12

28.06

GPM (%)

27.66

27.71

26.72

30.26

28.64

NPM (%)

18.49

18.76

18.15

20.67

19.77